pyruvaldehyde has been researched along with antipyrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, H; He, P; Hu, Y; Li, W; Ni, Z; Xu, H; Zhang, Z | 1 |
| Bocsik, A; Couraud, PO; Deli, MA; Dohgu, S; Kataoka, Y; Nagy, L; Puskás, LG; Sántha, P; Takata, F; Tóth, AE; Veszelka, S; Walter, FR | 1 |
2 other study(ies) available for pyruvaldehyde and antipyrine
| Article | Year |
|---|---|
Edaravone protected human brain microvascular endothelial cells from methylglyoxal-induced injury by inhibiting AGEs/RAGE/oxidative stress.
Topics: Antipyrine; Blotting, Western; Brain; Diabetes Complications; Edaravone; Endothelial Cells; Glycation End Products, Advanced; Humans; Microvessels; Oxidative Stress; Pyruvaldehyde; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Rhodamine 123; Tetrazolium Salts; Thiazoles | 2013 |
Edaravone protects against methylglyoxal-induced barrier damage in human brain endothelial cells.
Topics: Antipyrine; beta Catenin; Blood-Brain Barrier; Cell Line; Cell Survival; Claudin-5; Edaravone; Electric Impedance; Endothelial Cells; Endothelium, Vascular; Free Radical Scavengers; Guanidines; Humans; Oxidative Stress; Permeability; Protective Agents; Pyruvaldehyde; Reactive Oxygen Species; Tight Junctions | 2014 |